Navigation Links
FluChip technology licensed to combat deadly flu virus
Date:4/28/2009

Boulder, CO, 4-28-09. InDevR, a small biotech company in Boulder, CO, announced today that they have licensed the FluChip technology from the University of Colorado. The FluChip was invented by a joint team of scientists at the University of Colorado and the Centers for Disease Control and Prevention in an NIH sponsored effort led by Professor Kathy Rowlen.

Rowlen, now the CEO of InDevR, said that InDevR has arranged to test genetic material from the recent swine H1N1 virus on the MChip as well as other versions of the FluChip which are under development.

According to Rowlen "Based on work we conducted a couple of years ago, it appears that the M-gene version of the FluChip will be able to distinguish human H1N1 viruses from the new swine H1N1 virus. If that proves to be the case, the FluChip will be a much needed and powerful new tool for surveillance since all of the current influenza diagnostics on the market are unable to subtype this virus."

The most popular diagnostic tests for influenza include rapid immunoassays, which are only able to identify the type (A or B) of influenza virus, and reverse-transcriptase polymerase chain reaction assays, which were designed for human-adapted influenza viruses and are not able to identify the swine H1N1 subtype. State Public Health Laboratories must now send any influenza A viruses that cannot be subtyped using existing diagnostics to the CDC for analysis by genome sequencing or viral isolation.

The CDC must select viruses to analyze since it is not possible to run every sample collected from a large number of Public Health Labs.

The M-gene based FluChip has been demonstrated to delineate human-adapted viruses from non-human viruses, such as the H1N1 virus that caused the 1918 "Spanish Flu". "Since the FluChip assay can be conducted within a single day it could be employed in State Public Health Laboratories to greatly enhance influenza surveillance and our ability to track the virus," Rowlen said.

InDevR will combine the FluChip technology with an innovative detection technology (NESATM), which InDevR also licensed from the University of Colorado and further developed with NIH sponsorship, to make the FluChip assay inexpensive and easy to use in any lab that has basic PCR capabilities.

"Kathy and her team have been engaged with this and similar diagnostic technology for many years," said Mary Tapolsky, Senior Licensing Manager at the University of Colorado Technology Transfer Office. "CU TTO is excited about this experienced and motivated group developing and commercializing this promising technology."


'/>"/>

Contact: Kathy Rowlen
rowlen@indevr.com
303-402-9100
University of Colorado at Boulder
Source:Eurekalert

Related biology news :

1. BIO-key(R) International Showcasing Biometric Identification Technology at 2009 RSA Conference
2. Combating Terrorism with Commercial Technology: 2009 Force Protection Equipment Demonstration
3. Conference tackles technology needed to address climate change
4. Childrens Hospital Oakland is first pediatric hospital to use laboratory-on-a-card technology
5. Olympus advances technology for laparo-endoscopic single-site surgery
6. Ancient diatoms lead to new technology for solar energy
7. Nanofarming technology harvest biofuel oils without harming algae
8. Cellulosic biofuel technology will generate low-cost green fuel, says major study
9. Ben-Gurion University of the Negev researchers develop new reversible, green window technology
10. Salient Stills Notches Significant Advances in Profitability, Diversity of Sales and Customers, and Video Forensics Technology in 2008
11. QSGI Integrates Fujitsu Mag EraSURE Data Degausser into its Suite of Information Technology Security Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... 2017   Acuant , a leading provider of ... enhancements to new and core technologies building upon the ... mobile and desktop Acuant FRM TM facial recognition ... real time manual review of identity documents by accredited ... fastest and most accurate capture software to streamline workflows ...
(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... Norwood, MA (PRWEB) , ... March 29, 2017 , ... ... year centered on patient-involved research, Colpitts Clinical Trial Travel has announced that it will ... of Direct Travel, was among the first in the United States and Europe to ...
(Date:3/29/2017)... SAN DIEGO and NEWARK, Del. ... Inc. , a privately-held regenerative medicine company, and ... global materials science company, today announced a collaborative research ... develop novel implantable cell therapy delivery device technologies that ... more than a decade, ViaCyte has been developing innovative ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Association for the Advancement of Science (AAAS), the world's largest general scientific ... enhance its high-impact scholarly collection across its cross-platform reference management system. , ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... Phase II Small Business Innovation Research (SBIR) grant from the National Science Foundation ... over two years to develop a suite of BioGel™ biopolymer materials for hygiene ...
Breaking Biology Technology: